Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
BackgroundMischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., & Mushinski, J. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53223-3 · Cited by 541
Self-citationGraff, J. R., McNulty, A. M., Hanna, K. R., Konicek, B. W., Lynch, R. L., Bailey, S. N., Banks, C., Capen, A., Goode, R., Lewis, J. E., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0071 · Cited by 442
Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ
Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., Tsukiyama, T., Nagahama, H., Ohno, S., Hatakeyama, S., et al. (2002) · Nature · doi:10.1038/416865a · Cited by 420 · cited 1×
“Although there are no reports of increased cancer susceptibility in Pkcd -null mice, these animals show enhanced B-cell proliferatio”
BackgroundRasGRP is essential for mouse thymocyte differentiation and TCR signaling
Dower, N. A., Stang, S. L., Bottorff, D. A., Ebinu, J. O., Dickie, P., Ostergaard, H. L., & Stone, J. C. (2000) · Nature Immunology · doi:10.1038/79766 · Cited by 411
Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1
Bivona, T. G., Pérez de Castro, I., Ahearn, I. M., Grana, T. M., Chiu, V. K., Lockyer, P. J., Cullen, P. J., Pellicer, A., Cox, A. D., & Philips, M. R. (2003) · Nature · doi:10.1038/nature01806 · Cited by 402
Distinctive activation mechanisms and functions for protein kinase Cδ
STEINBERG, S. F. (2004) · Biochemical Journal · doi:10.1042/bj20040704 · Cited by 376 · cited 1×
“There has been speculation that the dual role of PKCδ, both as a positive or negative growth regulator, relates to its differential tyrosine-phosphorylation statu”
BackgroundAdaptor proteins in protein kinase C-mediated signal transduction
Schechtman, D., & Mochly-Rosen, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204778 · Cited by 352
Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation
Lu, Z., Liu, D., Hornia, A., Devonish, W., Pagano, M., & Foster, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.839 · Cited by 334
PKD at the crossroads of DAG and PKC signaling
Wang, Q. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.003 · Cited by 331 · cited 1×
“In the case of PKDs, some reports have linked these kinases to mitogenesis, motility and invasio”
BackgroundNg, T., Shima, D., Squire, A., Bastiaens, P. I. H., Gschmeissner, S., Humphries, M. J., & Parker, P. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3909 · Cited by 330 · cited 1×
“PKCα has been shown to directly interact with β1-integrin and increase migration on β1-integrin substrates, possibly through regulation of internalization and recycling of β1-integri”
BackgroundRasGRP links T-cell receptor signaling to Ras
Ebinu, J. O., Stang, S. L., Teixeira, C., Bottorff, D. A., Hooton, J., Blumberg, P. M., Barry, M., Bleakley, R. C., Ostergaard, H. L., & Stone, J. C. (2000) · Blood · doi:10.1182/blood.v95.10.3199 · Cited by 327 · cited 1×
“In T cells, RasGRP1 couples the T-cell receptor (TCR) to the ERK cascad”
BackgroundProtein kinase D mediates a stress-induced NF-kappaB activation and survival pathway
Storz, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg009 · Cited by 325
Hoelzinger, D. B., Mariani, L., Weis, J., Woyke, T., Berens, T. J., McDonough, W., Sloan, A., Coons, S. W., & Berens, M. E. (2005) · Neoplasia · doi:10.1593/neo.04535 · Cited by 323 · cited 1×
“There is emerging information that chimaerins are downregulated in cancer, such as in high-grade gliomas and breast cance”
BackgroundWolfman, A., & Macara, I. G. (1987) · Nature · doi:10.1038/325359a0 · Cited by 315 · cited 1×
“Phorbol esters were found to cooperate with the Ras oncogenes for transformation, and deregulated production of DAG was observed in Ras-transformed cells, indicating that Ras and PKC might cooperate during transformatio”
BackgroundC1 domains exposed: From diacylglycerol binding to protein–protein interactions
COLONGONZALEZ, F., & KAZANIETZ, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.05.001 · Cited by 308 · cited 1×
“Even the C1 domain could be involved in intracellular targeting through interaction with proteins in addition to serving as a lipid-binding domai”
BackgroundSelf-citationCompetitive inhibition by diacylglycerol of specific phorbol ester binding.
Sharkey, N. A., Leach, K. L., & Blumberg, P. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.607 · Cited by 306 · cited 1×
“The fact that DAG could displace phorbol esters from their binding site in PKC represented the first compelling evidence that a bioactive lipid product could modulate a kinase linked to carcinogenesi”
BackgroundProtein Kinase Czeta (PKCzeta): Activation Mechanisms and Cellular Functions
Hirai, T. (2003) · Journal of Biochemistry · doi:10.1093/jb/mvg017 · Cited by 304
Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., & Kufe, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000048200 · Cited by 297
Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol.
Leach, K. L., James, M. L., & Blumberg, P. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4208 · Cited by 288 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundWu, L.-W., Mayo, L. D., Dunbar, J. D., Kessler, K. M., Baerwald, M. R., Jaffe, E. A., Wang, D., Warren, R. S., & Donner, D. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5096 · Cited by 286 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
BackgroundLi, L., Lorenzo, P. S., Bogi, K., Blumberg, P. M., & Yuspa, S. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8547 · Cited by 281
Protein Kinase C δ Is Essential for Etoposide-induced Apoptosis in Salivary Gland Acinar Cells
Reyland, M. E., Anderson, S. M., Matassa, A. A., Barzen, K. A., & Quissell, D. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19115 · Cited by 269 · cited 1×
“Several chemotherapeutic agents, such as etoposide or cisplatin and UV radiation, induce the generation of the catalytic PKCδ fragment and, remarkably, their apoptotic efficacy is severely impaired when PKCδ function or expression is inhibite”
BackgroundWays, D. K., Kukoly, C. A., deVente, J., Hooker, J. L., Bryant, W. O., Posekany, K. J., Fletcher, D. J., Cook, P. P., & Parker, P. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117872 · Cited by 266
Protein kinase C binding partners
Jaken, S., & Parker, P. J. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3<245::aid-bies6>3.0.co;2-x · Cited by 260 · cited 1×
“It has been postulated that this might relate to distinct protein–protein and lipid–protein interactions, such as PKC interaction with the scaffolding protein RACK1 (Ref”
BackgroundMechanisms of multistep carcinogenesis and carcinogen risk assessment.
Barrett, J. C. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.931009 · Cited by 246
Tanaka, Y., Gavrielides, M. V., Mitsuuchi, Y., Fujii, T., & Kazanietz, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303313200 · Cited by 244 · cited 1×
“In prostate cancer models with phosphatase and tensin homologue ( PTEN ) deficiency, such as LNCaP cells, phorbol esters cause the dephosphorylation and inactivation of Akt, probably through the activation of a PP2A phosphatas”
BackgroundSelf-citationFrasch, S. C., Henson, P. M., Kailey, J. M., Richter, D. A., Janes, M. S., Fadok, V. A., & Bratton, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003116200 · Cited by 234
Nuclear import of PKCδ is required for apoptosis: identification of a novel nuclear import sequence
DeVries, T. A., Neville, M. C., & Reyland, M. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf606 · Cited by 231
Hennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., & Yuspa, S. H. (1987) · Carcinogenesis · doi:10.1093/carcin/8.9.1343 · Cited by 230 · cited 1×
“; second, bryostatin 1, which protects PKCδ from downregulation, blocks phorbol-ester-induced tumour promotio”
BackgroundDenning, M. F., Wang, Y., Nickoloff, B. J., & Wrone-Smith, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29995 · Cited by 228
Storz, P., Döppler, H., & Toker, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2614-2626.2004 · Cited by 227
The atypical protein kinase Cs: Functional specificity mediated by specific protein adapters
Moscat, J., & Diaz‐Meco, M. T. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd098 · Cited by 217 · cited 1×
“aPKCs are unresponsive to either calcium or DAG and will not be discussed in this review, but information on these PKCs can be found elsewher”
BackgroundPKC-δ is an apoptotic lamin kinase
Cross, T., Griffiths, G., Deacon, E., Sallis, R., Gough, M., Watters, D., & Lord, J. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203555 · Cited by 216
Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cδ: Implications for Apoptosis
Bharti, A., Kraeft, S.-K., Gounder, M., Pandey, P., Jin, S., Yuan, Z.-M., Lees-Miller, S. P., Weichselbaum, R., Weaver, D., Chen, L. B., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6719 · Cited by 208
Tumor Promotion by Depleting Cells of Protein Kinase Cδ
Lu, Z., Hornia, A., Jiang, Y.-W., Zang, Q., Ohno, S., & Foster, D. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3418 · Cited by 207
Denning, M. F., Wang, Y., Tibudan, S., Alkan, S., Nickoloff, B. J., & Qin, J.-Z. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400929 · Cited by 206
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Paolo Dotto, G., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 204
Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P. M., & Brodie, C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.182-195.2002 · Cited by 197
The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival
Jackson, D. N., & Foster, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0979rev · Cited by 195 · cited 1×
“By contrast, PKCδ has been shown to convey anti-proliferative and apoptotic signals in various cell type”
BackgroundYoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Tsujinoue, H., Nakatani, T., Shibuya, M., et al. (1999) · PubMed · Cited by 194
Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., Umansky, F., Lorenzo, P. S., Blumberg, P. M., & Brodie, C. (2001) · PubMed · Cited by 184
Pardo, O. E., Wellbrock, C., Khanzada, U. K., Aubert, M., Arozarena, I., Davidson, S., Bowen, F., Parker, P. J., Filonenko, V. V., Gout, I. T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601198 · Cited by 183 · cited 1×
“Overexpression of PKCe in lung cancer cells is sufficient to induce mitogen-activated protein kinase kinase (MAPKK or MEK)–ERK activation and upregulate pro-survival factors BCL-X L and X-linked inhibitor of apoptosis ( XIAP”
BackgroundGallegos, L. L., Kunkel, M. T., & Newton, A. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603741200 · Cited by 183
Wang, Q. J., Bhattacharyya, D., Garfield, S., Nacro, K., Marquez, V. E., & Blumberg, P. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37233 · Cited by 181 · cited 1×
“Indeed, in response to either phorbol esters or receptor stimulation, PKC isozymes can redistribute to the nuclear membrane or to organelles such as the mitochondria (see below) or the Golgi apparatu”
BackgroundMurray, N. R., Davidson, L. A., Chapkin, R. S., Clay Gustafson, W., Schattenberg, D. G., & Fields, A. P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.4.699 · Cited by 181 · cited 1×
“gov/cancertopics/types/colon-and-rectal/">colon cancer”
Riobo, N. A., Haines, G. M., & Emerson, C. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2539 · Cited by 181
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
Gökmen‐Polar, Y., Murray, N. R., Velasco, M. A. D., Gatalica, Z., & Fields, A. P. (2001) · PubMed · Cited by 180
Wong, C., & Jin, Z.-G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503198200 · Cited by 176
Hall, C., Monfries, C., Smith, P., Lim, H. H., Kozma, R., Ahmed, S., Vanniasingham, V., Leung, T., & Lim, L. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90006-8 · Cited by 174 · cited 1×
“Chimaerins were identified in the early 1990s as 'chimaeras' between PKCs (for their C1 domain) and the BCR protein (for their GTPase-activating protein or GAP domain”
BackgroundKinoshita, N., Iioka, H., Miyakoshi, A., & Ueno, N. (2003) · Genes & Development · doi:10.1101/gad.1101303 · Cited by 173 · cited 1×
“On the other hand, recent research showing that pro-tumorigenic sonic hedgehog ( SHH ) signalling and Wnt signalling are dependent on PKCδ indicate a broader role for this PKC in cancer than originally though”
BackgroundSuzuma, K., Takahara, N., Suzuma, I., Isshiki, K., Ueki, K., Leitges, M., Aiello, L. P., & King, G. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022644499 · Cited by 170
Liu, J.-F., Crépin, M., Liu, J.-M., Barritault, D., & Ledoux, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00350-9 · Cited by 167 · cited 1×
“PKC isozymes have also been implicated in regulating the secretion or expression of basement membrane-remodelling proteins such as matrix metalloproteinase protein 9 ( MMP9 ) or members of the urokinase-type plasminogen activator receptor ( uPAR ) pathwa”
BackgroundUbiquitination of Protein Kinase C-α and Degradation by the Proteasome
Lee, H.-W., Smith, L., Pettit, G. R., Vinitsky, A., & Smith, J. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.20973 · Cited by 163
PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
Cacace, A. M., Ueffing, M., Philipp, A., Han, E. K.-H., Kölch, W., & Weinstein, I. B. (1996) · PubMed · Cited by 157
Frey, M. R., Saxon, M. L., Zhao, X., Rollins, A., Evans, S. S., & Black, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9424 · Cited by 156
Suppression of Apoptosis in the Protein Kinase Cδ Null Mouse in Vivo
Humphries, M. J., Limesand, K. H., Schneider, J. C., Nakayama, K. I., Anderson, S. M., & Reyland, M. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507851200 · Cited by 155
Reddig, P. J., Dreckschmidt, N. E., Ahrens, H., Simsiman, R. C., Tseng, C. P., Zou, J., Oberley, T. D., & Verma, A. K. (1999) · PubMed · Cited by 154
RasGRP1 and RasGRP3 Regulate B Cell Proliferation by Facilitating B Cell Receptor-Ras Signaling
Coughlin, J. J., Stang, S. L., Dower, N. A., & Stone, J. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7179 · Cited by 153 · cited 1×
“In B cells, both RasGRP1 and RasGRP3 link B-cell-receptor signalling to the ERK cascad”
BackgroundProtein kinase C-mediated regulation of the cell cycle
Black, J. (2000) · Frontiers in Bioscience · doi:10.2741/black · Cited by 151 · cited 1×
“PKC in proliferation and cell-cycle regulation The role of PKC in modulating cellular proliferation is well documented, but the role of specific PKC isozymes in controlling cell-cycle events is still quite controversia”
BackgroundActivation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation
Yuan, Z.-M., Utsugisawa, T., Ishiko, T., Nakada, S., Huang, Y., Kharbanda, S. M., Weichselbaum, R. R., & Kufe, D. W. (1998) · Oncogene · doi:10.1038/sj.onc.1201698 · Cited by 146 · cited 1×
“A crucial player in this mechanism seems to be ABL , which phosphorylates PKCδ in response to apoptotic stimuli and promotes its nuclear translocatio”
BackgroundPan, Q., Bao, L. W., Kleer, C. G., Sabel, M. S., Griffith, K. A., Teknos, T. N., & Merajver, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0553 · Cited by 145
Protein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer
Cornford, P. A., Evans, J., Dodson, A. R., PARSONS, K. F., Woolfenden, A., Neoptolemos, J. P., & Foster, C. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65260-1 · Cited by 144
Blay, P., Astudillo, A., Buesa, J., Campo, E., Abad, M., García-García, J., Miquel, R., Marco, V., Sierra, M., Losa, R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0630 · Cited by 143
Pongracz, J., Clark, P., Neoptolemos, J. P., & Lord, J. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610107 · Cited by 137
Zhang, J., Anastasiadis, P. Z., Liu, Y., Thompson, E. A., & Fields, A. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400774200 · Cited by 135 · cited 1×
“The transforming effect is mediated by a PKCβII–Ras–PKCι– RAC1 –MEK pathway and it is highly sensitive to a MEK inhibito”
BackgroundWang, H. Q., & Smart, R. C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.20.3497 · Cited by 134
Suzuki, A. (2003) · Journal of Biochemistry · doi:10.1093/jb/mvg018 · Cited by 129
Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C
Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B., & BRESSION, D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077302 · Cited by 129
Parsons, M., Epple, M., Kline, A. D., Messent, A., Humphries, M. J., Gilchrist, R., Hart, I. R., Prévostel, C., Hughes, W. E., Parker, P. J., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5897-5911.2002 · Cited by 123 · cited 1×
“Furthermore, disruption of the PKCα–β1-integrin association blocks chemotactic migratio”
BackgroundExpression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
Hans, C. P., Weisenburger, D. D., Greiner, T. C., Chan, W. C., Aoun, P. A., Cochran, G. T., Pan, Z., Smith, L. M., Lynch, J. C., Bociek, R. G., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800434 · Cited by 120
Tan, M., Li, P., Sun, M., Yin, G., & Yu, D. (2005) · Oncogene · doi:10.1038/sj.onc.1209361 · Cited by 119
Giorgione, J. R., Lin, J.-H., McCammon, J. A., & Newton, A. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510251200 · Cited by 118
Gubina, E., Rinaudo, M. S., Szállási, Z., Blumberg, P. M., & Mufson, R. A. (1998) · Blood · doi:10.1182/blood.v91.3.823 · Cited by 117
Involvement of Functional Protein Kinase C in the Mitogenic Response to the H-ras Oncogene Product
Lacal, J. C., Fleming, T. P., Warren, B. S., Blumberg, P. M., & Aaronson, S. A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.11.4146 · Cited by 117
Szállási, Z., Denning, M. F., Smith, C. B., Dlugosz, A. A., Yuspa, S. H., Pettit, G. R., & Blumberg, P. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09823-2 · Cited by 116
Kaul, S., Anantharam, V., Yang, Y., Choi, C. J., Kanthasamy, A., & Kanthasamy, A. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501092200 · Cited by 115
Borner, C., Ueffing, M., Jaken, S., Parker, P. J., & Weinstein, I. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.78 · Cited by 114
Protein Kinase C α but not PKCζ Suppresses Intestinal Tumor Formation in ApcMin/+ Mice
Oster, H., & Leitges, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0268 · Cited by 112
Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium
Frey, M. R., Clark, J. A., Leontieva, O., Uronis, J. M., Black, A. R., & Black, J. D. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.4.763 · Cited by 111 · cited 1×
“PKCα is thought to be important for inducing the normal cell-cycle withdrawal that is seen as intestinal cells migrate out of the intestinal crypt”
BackgroundDing, L., Wang, H., Lang, W., & Xiao, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201460200 · Cited by 110 · cited 1×
“gov/cancertopics/types/lung/">non-small-cell lung carcinoma cell”
Zheng, Y., Liu, H., Coughlin, J., Zheng, J., Li, L., & Stone, J. C. (2005) · Blood · doi:10.1182/blood-2004-10-3916 · Cited by 109 · cited 1×
“This represents a positive regulatory modification, as a T133A mutant shows defective nucleotide-exchange activity and activates Ras, ERK and proliferation less efficientl”
BackgroundImplication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C
Madani, S., Hichami, A., Legrand, A., Belleville, J., & Khan, N. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0753int · Cited by 108
Leontieva, O. V., & Black, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308375200 · Cited by 107
Protein Kinase C-ε Regulates the Apoptosis and Survival of Glioma Cells
Okhrimenko, H., Lu, W., Xiang, C., Hamburger, N., Kazimirsky, G., & Brodie, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1064 · Cited by 107
Kim, R., Trubetskoy, A., Suzuki, T., Jenkins, N. A., Copeland, N. G., & Lenz, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2056-2062.2003 · Cited by 103
Diacylglycerol kinase δ regulates protein kinase C and epidermal growth factor receptor signaling
Crotty, T., Cai, J., Sakane, F., Taketomi, A., Prescott, S. M., & Topham, M. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604104103 · Cited by 102
Reddig, P. J., Dreckschmidt, N. E., Zou, J., Bourguignon, S. E., Oberley, T. D., & Verma, A. K. (2000) · PubMed · Cited by 99
Yang, Y., Li, L., Wong, G. W., Krilis, S. A., Madhusudhan, M. S., Šali, A., & Stevens, R. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202575200 · Cited by 98
Luo, B., Regier, D. S., Prescott, S. M., & Topham, M. K. (2004) · Cellular Signalling · doi:10.1016/s0898-6568(04)00056-7 · Cited by 98
Sharif, T. R., & Sharif, M. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.2.237 · Cited by 97
Rac-GAP-dependent Inhibition of Breast Cancer Cell Proliferation by β2-Chimerin
Yang, C., Liu, Y., Leskow, F. C., Weaver, V. M., & Kazanietz, M. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411629200 · Cited by 95 · cited 1×
“As predicted from their Rac-GAP activity, chimaerins have been found to inhibit Rac-dependent functions, including actin-cytoskeleton reorganization, migration, cell-cycle progression and metastatic disseminatio”
BackgroundSelf-citationGarcia-Bermejo, M. L., Leskow, F. C., Fujii, T., Wang, Q., Blumberg, P. M., Ohba, M., Kuroki, T., Han, K.-C., Lee, J., Marquez, V. E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107639200 · Cited by 95 · cited 1×
“Indeed, in response to either phorbol esters or receptor stimulation, PKC isozymes can redistribute to the nuclear membrane or to organelles such as the mitochondria (see below) or the Golgi apparatu”
BackgroundSelf-citationLu, D., Huang, J., & Basu, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603390200 · Cited by 94
Prevostel, C., Alice, V., Joubert, D., & Parker, P. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.14.2575 · Cited by 94
Clark, J. A., Black, A. R., Leontieva, O. V., Frey, M. R., Pysz, M. A., Kunneva, L., Woloszynska‐Read, A., Roy, D., & Black, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312268200 · Cited by 93 · cited 1×
“G1 arrest occurs, with a corresponding increase in the expression levels of the cyclin-dependent kinase inhibitors p21 and p27 , a decrease in retinoblastoma ( RB ) phosphorylation and sustained extracellular signal-regulated kinase (ERK) activatio”
BackgroundHsiao, W. L. W., Housey, G. M., Johnson, M. D., & Weinstein, I. B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2641 · Cited by 92
MacDonald, M. L., Mack, K. F., Richardson, C. N., & Glomset, J. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57343-4 · Cited by 90
Querfeld, C., Rizvi, M. A., Kuzel, T. M., Guitart, J., RADEMAKER, A. W., Sabharwal, S. S., Krett, N. L., & Rosen, S. T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700322 · Cited by 89
Nakagawa, M., Oliva, J. L., Kothapalli, D., Fournier, A. K., Assoian, R. K., & Kazanietz, M. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505748200 · Cited by 88
Self-citationMihailovic, T., Marx, M., Auer, A., Lint, J. V., Schmid, M., Weber, C. K., & Seufferlein, T. T. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0981 · Cited by 87
Pan, Q., Bao, L., Teknos, T. N., & Merajver, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2646 · Cited by 87
Detjen, K. M., Brembeck, F. H., Welzel, M., Kaiser, A., Haller, H. G., Wiedenmann, B. J., & Rosewicz, S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.17.3025 · Cited by 87
Gonzalez-Guerrico, A. M., & Kazanietz, M. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506767200 · Cited by 83 · cited 1×
“gov/cancertopics/types/prostate/">prostate cancer cells has determined that PKCδ can trigger an autocrine apoptotic loop through the secretion of TNFα and TRAI”
BackgroundSelf-citationRegulation of Ras in lymphocytes: get a GRP
Stone, J. C. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340858 · Cited by 81 · cited 1×
“Whereas all RasGRPs promote exchange activity on Ras, RasGRP2 and RasGRP3 also have RAP1 GEF activit”
BackgroundSlíva, D., English, D. K., Lyons, D., & Lloyd, F. P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6225 · Cited by 81 · cited 1×
“PKC isozymes have also been implicated in regulating the secretion or expression of basement membrane-remodelling proteins such as matrix metalloproteinase protein 9 ( MMP9 ) or members of the urokinase-type plasminogen activator receptor ( uPAR ) pathwa”
BackgroundCataisson, C., Pearson, A., Torgerson, S., Nedospasov, S. A., & Yuspa, S. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1686 · Cited by 80
Wheeler, D. L., Ness, K. J., Oberley, T. D., & Verma, A. K. (2003) · PubMed · Cited by 78
Wellner, M., Maasch, C., Kupprion, C., Lindschau, C., Luft, F. C., & Haller, H. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.178 · Cited by 78 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
BackgroundChida, K., Hara, T., Hirai, T., Konishi, C., Nakamura, K., Nakao, K., Aiba, A., Katsuki, M., & Kuroki, T. (2003) · PubMed · Cited by 76
Hornia, A., Lu, Z., Sukezane, T., Zhong, M., Joseph, T. W., Frankel, P., & Foster, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7672 · Cited by 76 · cited 1×
“Suppression of PKCδ expression or activity induces or favours a transformed phenotyp”
BackgroundPKCδ acts as a growth and tumor suppressor in rat colonic epithelial cells
Perletti, G. P., Marras, E., Concari, P., Piccinini, F., & Tashjian, A. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202408 · Cited by 75
Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis
Yu, W., Murray, N. R., Weems, C., Chen, L., Guo, H., Ethridge, R., Ceci, J. D., Evers, B. M., Thompson, E. A., & Fields, A. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211424200 · Cited by 74 · cited 1×
“These mice have increased colonic β-catenin and cyclooxygenase 2 ( PTGS2 ) expression levels, and transforming growth-factor receptor βII (TGFRβII) expression is markedly represse”
BackgroundInvolvement of Protein Kinase Cε (PKCε) in Thyroid Cell Death
Knauf, J. A., Elisei, R., Mochly‐Rosen, D., Liron, T., Chen, X., Gonsky, R., Korenberg, J. R., & Fagin, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23414 · Cited by 73
Benzil, D. L., Finkelstein, S. D., Epstein, M. H., & Finch, P. W. (1992) · PubMed · Cited by 73
PKCθ mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia
Felli, M. P., Vacca, A., Calce, A., Bellavia, D., Campese, A. F., Grillo, R., Giovine, M. D., Checquolo, S., Talora, C., Palermo, R., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208302 · Cited by 73
Shindo, M., Irie, K., Masuda, A., Ohigashi, H., Shirai, Y., Miyasaka, K., & Saito, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300400200 · Cited by 70
Hall, C., Michael, G. J., Cann, N., Ferrari, G., Teo, M., Jacobs, T., Monfries, C., & Lim, L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05191.2001 · Cited by 70 · cited 1×
“Their function remained obscure for many years, but recent work has shed light on their role in neuritogenesis, development and cance”
BackgroundWeichert, W., Gekeler, V., Denkert, C., Dietel, M., & Hauptmann, S. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.3.633 · Cited by 69
Protein kinase C δ enhances proliferation and survival of murine mammary cells
Grossoni, V. C., Falbo, K. B., Kazanietz, M. G., de Kier Joffé, E. D. B., & Urtreger, A. J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20287 · Cited by 69
Self-citationVarga, A., Czifra, G., Tállai, B., Németh, T., Kovács, I., Kovács, L., & Bíró, T. (2004) · European Urology · doi:10.1016/j.eururo.2004.04.014 · Cited by 67
Kerfoot, C. A., Huang, W., & Rotenberg, S. A. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540405200314 · Cited by 66
Yuan, S., Miller, D. W., Barnett, G. H., Hahn, J. F., & Williams, B. R. G. (1995) · PubMed · Cited by 66
Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A., & Sampson, S. R. (2001) · American Journal of Clinical Pathology · doi:10.1309/1vkk-hwh7-yvjn-7uf7 · Cited by 66
The diacylglycerol-binding protein α1-chimaerin regulates dendritic morphology
Buttery, P., Beg, A. A., Chih, B., Broder, A., Mason, C. A., & Scheiffele, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510655103 · Cited by 65
Bacchiocchi, R., Baldanzi, G., Carbonari, D., Capomagi, C., Colombo, E., van Blitterswijk, W. J., Graziani, A., & Fazioli, F. (2005) · Blood · doi:10.1182/blood-2005-01-0316 · Cited by 65
Verstovsek, G., Byrd, A. E., Frey, M. R., Petrelli, N. J., & Black, J. D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70367-1 · Cited by 64
The proapoptotic tumor suppressor protein kinase C-δ is lost in human squamous cell carcinomas
D'Costa, A. M., Robinson, J. K., Maududi, T., Chaturvedi, V., Nickoloff, B. J., & Denning, M. F. (2005) · Oncogene · doi:10.1038/sj.onc.1209065 · Cited by 62
Wang, H., Yang, C., Leskow, F. C., Sun, J., Canagarajah, B. J., Hurley, J. H., & Kazanietz, M. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601098 · Cited by 62 · cited 1×
“Tyrosine-kinase receptors and GPCRs can activate chimaerins through the PLC–DAG pathway, leading to their redistribution to the plasma membrane and association with Ra”
BackgroundSelf-citationDiacylglycerol Kinase γ Serves as an Upstream Suppressor of Rac1 and Lamellipodium Formation
Tsushima, S., Kai, M., Yamada, K., Imai, S.-I., Houkin, K., Kanoh, H., & Sakane, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314031200 · Cited by 60
Suppression of cell migration by protein kinase Cδ
Jackson, D. N., Yang, Z., Lyo, D., Shen, Y., Nakayama, K., Nakayama, K., Humphries, M. J., Reyland, M. E., & Foster, D. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208465 · Cited by 60
Antisense Targeting Protein Kinase C α and β1 Inhibits Gastric Carcinogenesis
Jiang, X.-H., Tu, S.-P., Cui, J.-T., Lin, M. C. M., Xia, H. H. X., Wong, W. M., Chan, A. O.-O., Yuen, M. F., Jiang, S.-H., Lam, S.-K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1172 · Cited by 59
Protein kinase C-mediated regulation of the cell cycle
Black, J. D. (2000) · Frontiers in bioscience · doi:10.2741/a522 · Cited by 57
Roberts, D. M., Anderson, A. L., Hidaka, M., Swetenburg, R. L., Patterson, C., Stanford, W. L., & Bautch, V. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10515-10528.2004 · Cited by 54 · cited 1×
“RasGRP3 has been identified in a vascular gene-trap screen for angiogenesis-regulated genes and is upregulated in endothelial cells during angiogenesis and in response to VEGF stimulatio”
BackgroundLiu, Y., Su, W., Thompson, E. A., Leitges, M., Murray, N. R., & Fields, A. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407701200 · Cited by 53
Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms
Gavrielides, M., Frijhoff, A., Conti, C., & Kazanietz, M. (2004) · Current Drug Targets · doi:10.2174/1389450043345380 · Cited by 53
Self-citationPu, Y., Perry, N. A., Yang, D., Lewin, N. E., Kedei, N., Braun, D. C., Choi, S. H., Blumberg, P. M., Garfield, S. H., Stone, J. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414132200 · Cited by 53 · cited 1×
“However, by taking advantage of subtle structural differences between C1 domains, it has become feasible to achieve a significant degree of selectivity for ligands that can discriminate not only between PKC isozymes, but also between PKCs and non-PKC DAG receptor”
BackgroundSchultz, A., Ling, M., & Larsson, C. U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313017200 · Cited by 53
Teicher, B. A., Menon, K., Álvarez, E., Shih, C., & Faul, M. M. (2002) · Investigational New Drugs · doi:10.1023/a:1016297611825 · Cited by 50
Rambaratsingh, R. A., Stone, J. C., Blumberg, P. M., & Lorenzo, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308240200 · Cited by 50
Protein Kinase C-β as a Therapeutic Target in Breast Cancer
SLEDGEJR, G., & Gökmen‐Polar, Y. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.019 · Cited by 50
Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).
Brenner, W., Färber, G., Herget, T., Wiesner, C., Hengstler, J. G., & Thüroff, J. W. (2003) · PubMed · Cited by 50
Madani, S., Hichami, A., Cherkaoui‐Malki, M., & Khan, N. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306252200 · Cited by 49 · cited 1×
“Moreover, an as-yet incompletely explored scenario is that DAG species with different acyl chains differentially regulate phorbol-ester receptor”
BackgroundAltered expression and localization of PKC eta in human breast tumors
Masso‐Welch, P. A., Winston, J. S., Edge, S., Darcy, K. M., Asch, H. L., Vaughan, M. M., & Ip, M. M. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1012265703669 · Cited by 47
Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cδ
Srivastava, J., Procyk, K. J., Iturrioz, X., & Parker, P. J. (2002) · Biochemical Journal · doi:10.1042/bj20020737 · Cited by 46
Beck, J. F., Bohnet, B., Brügger, D., Bader, P., Dietl, J., Scheper, R. J., Kandolf, R., Liu, C., NIETHAMMER, D., & Gekeler, V. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.13 · Cited by 46
Yoshida, K., Yamaguchi, T., Shinagawa, H., Taira, N., Nakayama, K. I., & Miki, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3414-3431.2006 · Cited by 45
Menna, P. L., Skilton, G., Leskow, F. C., Alonso, D. F., Gomez, D. E., & Kazanietz, M. G. (2003) · PubMed · Cited by 45
Self-citationHara, T., Saito, Y., Hirai, T., Nakamura, K., Nakao, K., Katsuki, M., & Chida, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4241 · Cited by 45
Gillespie, S., Zhang, X. D., & Hersey, P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0332 · Cited by 43
Tachado, S. D., Mayhew, M. W., Wescott, G. G., Foreman, T. L., Goodwin, C. D., McJilton, M. A., & Terrian, D. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10164 · Cited by 42
Knauf, J. A., Ward, L. S., Nikiforov, Y. E., Nikiforova, M. N., Puxeddu, E., Medvedovic, M., Liron, T., Mochly‐Rosen, D., & Fagin, J. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8441 · Cited by 41
Doi, S., Goldstein, C., Hug, H., & Weinstein, I. B. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110405 · Cited by 41
Leskow, F. C., Holloway, B. A., Wang, H., Mullins, M. C., & Kazanietz, M. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508585103 · Cited by 40 · cited 1×
“Their function remained obscure for many years, but recent work has shed light on their role in neuritogenesis, development and cance”
BackgroundSelf-citationDeregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors
Klinger, M., Guilbault, B., Goulding, R. E., & Kay, R. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208334 · Cited by 40
Czifra, G., Tóth, B. I., Marincsák, R., Juhász, I., KOVACS, I., Acs, P. I., Kovács, L., Blumberg, P. M., & Bı́ró, T. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.11.007 · Cited by 39 · cited 1×
“For example, PKCδ is required for the proliferative effect of insulin-like growth factor 1 ( IGF1”
BackgroundTransgenic Overexpression of RasGRP1 in Mouse Epidermis Results in Spontaneous Tumors of the Skin
Oki-Idouchi, C. E., & Lorenzo, P. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3080 · Cited by 39 · cited 1×
“Strikingly, overexpression of RasGRP1 in mouse epidermis led to spontaneous formation of skin tumours, indicating that RasGRP1 might be involved in skin tumorigenesi”
BackgroundUrtreger, A. J., Grossoni, V. C., Falbo, K. B., Kazanietz, M. G., & Joffé, E. B. D. K. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20066 · Cited by 39 · cited 1×
“PKC isozymes have also been implicated in regulating the secretion or expression of basement membrane-remodelling proteins such as matrix metalloproteinase protein 9 ( MMP9 ) or members of the urokinase-type plasminogen activator receptor ( uPAR ) pathwa”
BackgroundSelf-citationHeit, I., Wieser, R. J., Herget, T., Faust, D., Borchert-Stuhlträger, M., Oesch, F., & Dietrich, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204657 · Cited by 38
Levy, M. F., Pocsidio, J., Guillem, J. G., Forde, K. A., LoGerfo, P., & Weinstein, B. I. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02050625 · Cited by 37
PHORBOL ESTER RECEPTORS AND THE IN VITRO EFFECTS OF TUMOR PROMOTERS
Blumberg, P. M., Delclos, K. B., Dunn, J. A., Jaken, S., Leach, K. L., & Yeh, E. (1983) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1983.tb47836.x · Cited by 36
Teicher, B. A., Menon, K., Alvarez, E., Liu, P., Shih, C., & Mm, F. (2001) · PubMed · Cited by 36
Differential Expression of Protein Kinase C Isoforms in Human Colorectal Cancers
Kuranami, M., Powell, C. T., Hug, H., Zeno, Z., Cohen, A. M., & Guillem, J. G. (1995) · Journal of Surgical Research · doi:10.1006/jsre.1995.1036 · Cited by 35
Norment, A. M., Bogatzki, L. Y., Klinger, M., Ojala, E. W., Bevan, M. J., & Kay, R. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1141 · Cited by 35 · cited 1×
“, and RasGRP1 overexpression lowers the threshold of TCR signalling needed to trigger proliferation of CD8 + thymocyte”
BackgroundThe PKCα-D294G Mutant Found in Pituitary and Thyroid Tumors Fails to Transduce Extracellular Signals
Zhu, Y., Dong, Q., Tan, B. J., Lim, W. G., Zhou, S., & Duan, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4506 · Cited by 33 · cited 1×
“It confers a defect in translocation to the plasma membrane and consequently impairs substrate phosphorylatio”
BackgroundSlosberg, E. D., Klein, M. G., Yao, Y., Han, E. K.-H., Schieren, I., & Weinstein, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203083 · Cited by 33
Irie, K., Masuda, A., Shindo, M., Nakagawa, Y., & Ohigashi, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.008 · Cited by 32
Ainsworth, P. D., Winstanley, J. H. R., Pearson, J., Bishop, H., & Garrod, D. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.027 · Cited by 31
Siliceo, M., García‐Bernal, D., Carrasco, S., Díaz-Flores, E., Leskow, F. C., Teixidó, J., Kazanietz, M. G., & Mérida, I. (2005) · Journal of Cell Science · doi:10.1242/jcs.02722 · Cited by 31 · cited 1×
“Tyrosine-kinase receptors and GPCRs can activate chimaerins through the PLC–DAG pathway, leading to their redistribution to the plasma membrane and association with Ra”
BackgroundSelf-citationAltered expression of cyclins and c-fos in R6 cells that overproduce PKCε
Han, E. K.-H., Cacace, A. M., Sgambato, A., & Weinstein, I. B. (1995) · Carcinogenesis · doi:10.1093/carcin/16.10.2423 · Cited by 29
Gilhooly, E. M., Morse‐Gaudio, M., Bianchi, L., Reinhart, L., Rose, D. P., Connolly, J. M., Reed, J. A., & Albino, A. P. (2001) · Melanoma Research · doi:10.1097/00008390-200108000-00006 · Cited by 29
Persaud, S. D., Hoang, V., Huang, J., & Basu, A. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.149 · Cited by 28
Basu, A., & Weixel, K. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620416 · Cited by 27 · cited 1×
“gov/cancertopics/types/ovarian/">ovarian carcinoma cells also show increased PKCe expressio”
BackgroundTeicher, B. A., Menon, K., Álvarez, E., Galbreath, E. J., Shih, C., & Faul, M. M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100372 · Cited by 27
Koren, R., Langzam, L., Paz, A., Livne, P. M., Gal, R., & Sampson, S. R. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200006000-00013 · Cited by 26
Barr, L. F., Mabry, M., Nelkin, B. D., Tyler, G., May, W. S., & Baylin, S. B. (1991) · PubMed · Cited by 24
Protein Kinase C Alpha and Tumorigenesis of the Endocrine Gland
Prévostel, C., Martin, A., Alvaro, V., Jaffiol, C., & BRESSION, D. (2008) · Hormone Research · doi:10.1159/000185457 · Cited by 20 · cited 1×
“, and in thyroid follicular adenomas and carcinoma”
BackgroundAML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia
Barton, K., & Nucifora, G. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3<214::aid-bies2>3.0.co;2-i · Cited by 20
Teicher, B. A., Menon, K., Alvarez, E., Galbreath, E. J., Shih, C., & Faul, M. M. (2001) · PubMed · Cited by 19
Oberschmidt, O., Eismann, U., Schulz, L., Struck, S., Blatter, J., Mm, L., Ma, D., & Hanauske, A. R. (2005) · PubMed · Cited by 15
Post-transcriptional Destabilization of p21 by Protein Kinase C in Fibroblasts
Walker, J. L., Castagnino, P. A., Chung, B. M., Kazanietz, M. G., & Assoian, R. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609622200 · Cited by 10
Self-citationAltered expression of protein kinase C in adult T-cell leukemia cells.
Hidaka, M., Nakakuma, H., Kawaguchi, T., Nagakura, S., Horikawa, K., Okuno, Y., Kagimoto, T., & Takatsuki, K. (1992) · PubMed · Cited by 6
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., & Rizzuto, R. (2008) · Oncogene · doi:10.1038/onc.2008.308 · Cited by 1,157
“Oncogene Protein kinases C can have a dual function in apoptosis, that is, the activation of specific PKC isoforms may protect or induce cell death, often in a cell-type-specific manner (Lavin et al., 1996; Liu et al., 2002; Griner and Kazanietz, 2007).”
BackgroundKang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
“The family of PKC contains 12 isoforms, in which PKC-α, -β, -δ, and -ε has been reported to be activated during the development of DR [57,58].”
BackgroundElectrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Structural Basis of Protein Kinase C Isoform Function
Steinberg, S. F. (2008) · Physiological Reviews · doi:10.1152/physrev.00034.2007 · Cited by 872
“General reviews that examine the physiological consequences of PKC isoform activation in individual tissues have appeared elsewhere (21, 71, 119, 137, 139, 201, 230); these topics are beyond the scope of this review and will not be covered.”
Background
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.